We are thrilled to announce that Pharmidex now offers an in-house flow cytometry service powered by the Attune™ NxT Acoustic Flow Cytometer + CytKick Max Autosampler, combining precision, throughput and cutting-edge capability.

With this platform, we can deliver a wide array of flow cytometry assays:

• High-dimensional immunophenotyping (T cells, B cells, NK, myeloid, ILCs)
• Viability/apoptosis, mitochondrial health, ROS and cell cycle analyses
• Functional assays: cytokine staining, proliferation, degranulation
• High-throughput screening (96/384-well plates) for drug candidates
• Rare-event detection (CTCs, minimal residual disease)
• Kinetic assays (calcium flux, uptake, time-course studies)

Pharmidex will integrate this new capability with our existing services:

• Histology & imaging: correlate cell subsets with tissue architecture
• Biomarker analysis: cross-validate flow-based biomarker readouts with proteomics, ELISA and transcriptomics
• In vivo & disease models: combine flow readouts from tissues/fluids with in vivo pharmacology, toxicology and PK/PD
• Autoimmune & immuno-oncology studies: dissect immune cell phenotypes, function and kinetics in preclinical models

If you’re interested in using flow cytometry in your next study or discussing how it can enhance your current project with Pharmidex’s broader service portfolio, I’d love to hear from you.

🔗 Learn more about our full services: (https://lnkd.in/eAdhrhFp) (https://lnkd.in/e9uXhXiB)

#FlowCytometry #AttuneNxT #DrugDiscovery #Pharmidex #Immunology